Danazol one Month Treatment of Thrombocytopenia in Chronic Hepatitis C
article
OA: diamond
CC0
AI-generated summary
One month of danazol treatment significantly increased platelet counts in patients with chronic hepatitis C-related thrombocytopenia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Thrombocytopenia is frequently observed in patients with chronic hepatitis C virus. Moderate and severe thrombocytopenia (
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (9)
- Danazol for the Treatment of Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus via openalex
- Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin via openalex
- doi:10.1007/bf03165102 via openalex
- doi:10.1053/j.gastro.2013.10.012 via openalex
- doi:10.1002/ajh.1180 via openalex
- doi:10.1111/1440-1681.12451 via openalex
- doi:10.1016/j.amjmed.2003.12.024 via openalex
- doi:10.1056/nejm198306093082306 via openalex
- doi:10.1016/s0168-8278(02)00274-x via openalex
Source provenance
- openalex
- last seen: 2026-05-10T11:15:50.589188+00:00
License: CC0
· commercial use OK